<?xml version="1.0" encoding="UTF-8"?>
<abstract id="abs0005">
 <sec>
  <title>Purpose</title>
  <p>Lianhuaqingwen (LH) as traditional Chinese medicine (TCM) formula has been used to treat influenza and exerted broad-spectrum antiviral effects on a series of influenza viruses and immune regulatory effects Ding et al. (2017). The goal of this study is to demonstrate the antiviral activity of LH against the novel SARS-CoV-2 virus and its potential effect in regulating host immune response.</p>
 </sec>
 <sec>
  <title>Methods</title>
  <p>The antiviral activity of LH against SARS-CoV-2 was assessed in Vero E6 cells using CPE and plaque reduction assay. The effect of LH on virion morphology was visualized under transmission electron microscope. Pro-inflammatory cytokine expression levels upon SARS-CoV-2 infection in Huh-7 cells were measured by real-time quantitative PCR assays.</p>
 </sec>
 <sec>
  <title>Results</title>
  <p>LH significantly inhibited SARS-CoV-2 replication in Vero E6 cells and markedly reduced pro-inflammatory cytokines (TNF-Î±, IL-6, CCL-2/MCP-1 and CXCL-10/IP-10) production at the mRNA levels. Furthermore, LH treatment resulted in abnormal particle morphology of virion in cells.</p>
 </sec>
 <sec>
  <title>Conclusions</title>
  <p>LH significantly inhibits the SARS-COV-2 replication, affects virus morphology and exerts anti-inflammatory activity 
   <italic>in vitro.</italic> These findings indicate that LH protects against the virus attack, making its use a novel strategy for controlling the COVID-19 disease.
  </p>
 </sec>
</abstract>
